Signal active
Organization
Contact Information
Overview
Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
About
Biotechnology, Product Research
2020
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Tenpoint Therapeutics headquartered in Europe, operates in the Biotechnology, Product Research sector. The company focuses on Biotechnology and has secured $560.0M in funding across 8 round(s). With a team of 11-50 employees, Tenpoint Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Tenpoint Therapeutics, raised $70.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
1
6
0
$70.0M
Details
1
Tenpoint Therapeutics has raised a total of $70.0M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2023 | Early Stage Venture | 70.0M |
Investors
Tenpoint Therapeutics is funded by 14 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Eight Roads Ventures | - | FUNDING ROUND - Eight Roads Ventures | 70.0M |
Alex Pasteur | - | FUNDING ROUND - Alex Pasteur | 70.0M |
Tenpoint Therapeutics | - | FUNDING ROUND - Tenpoint Therapeutics | 70.0M |
F-Prime Capital | - | FUNDING ROUND - F-Prime Capital | 70.0M |
Recent Activity
There is no recent news or activity for this profile.